The FDA just completed its review of various studies and has concluded that women taking drospirenone-containing birth control pills (such as Yaz, Yasmin or Ocella) may have a higher risk of developing blood clots (such as deep vein thrombosis and/or pulmonary embolisms) than women taking progestin-containing birth control pills….as much as THREE TIMES THE RISK.

Click on this link to read the actual FDA warning: FDA Warning Regarding Drospirenone-containing Birth Control

What is Drospirenone?

Drospirenone is a synthetic version of progesterone (also known as progestin), which is a female hormone.  In combination with ethinyl estradiol, it is used as contraception, to treat moderate acne, and to treat premenstrual dysphoric disorder.

 

Required Label Change

The FDA is now requiring manufacturers of drospirenone-containing birth control pills to revise their labels to include the fact that some studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products, as opposed to birth control pills that contain levonorgestrel or some other progestins. The labels will also state, however, that some of the studies showed no increased risk of blood clots with drospirenone-containing products. 

If you have taken Yaz, Yasmin or Ocella and have developed blood clots, call Kogan & Associates immediately at 800-876-2303 to discuss potential compensation.

 

 

Lawyers throughout the nation who represent women who have been injured after taking Yaz/Yasmin birth control are currently being contacted by Bayer (the makers of Yaz/Yasmin) to possibly reach settlements for their clients with pulmonary embolism and/or deep vein thrombosis (DVT) claims.

Since February of 2012, approximately 11,300 lawsuits have been filed by attorneys representing Yaz victims, according to Bayer’s 2011 Annual Report. So far approximately 70 of these cases have been settled, and Bayer is continuing settlement discussions on a case-by-case basis with attorneys nationwide. Bayer is only focusing right now on injuries involving pulmonary embolism and deep vein thrombosis. Gall bladder injuries are not yet being reviewed.

Pradaxa Lawsuits Filed

March 27, 2012

Pradaxa is a blood thinner used to prevent strokes and blood clots in patients with atrial fibrillation.  The FDA is currently reviewing Pradaxa’s safety, after numerous reports of increased side effects.  The first three Pradaxa lawsuits (based on “failure to warn”) have been filed against the drug maker Boehringer Ingelheim in Louisiana, Tennessee, and Kentucky [...]

Read the full article →

Zoloft Lawsuit

February 2, 2012

On January 5, 2012, The St. Clair Record reported that mothers who believe that their infants suffered from serious birth defects due to the fact that the women were taking Zoloft during their pregnancies have joined a Zoloft lawsuit against Pfizer (the maker of Zoloft).  The litigation reportedly claims that pregnant women were prescribed Zoloft even [...]

Read the full article →

First Yaz Trial Postponed

January 6, 2012

Yaz and Yasmin are birth control contraceptives which contain the hormone drospirenone.  These contraceptives, manufactured by Bayer (Germany’s largest drugmaker), have been the focus of regulators due to potential safety issues, including potential increase risks of deep vein thrombosis, pulmonary embolisms, and gall bladder disease.  There are currently over 10,000 lawsuits alleging injuries due to Yaz [...]

Read the full article →

What You Need To Know About An IVC Filter

July 27, 2011

Here is a good article about IVC filters that I ran across and wanted to share it.  It was posted on ArticleTom.com: An inferior vena cava or IVC filter is a medical device which helps prevent the existence of a condition known as pulmonary embolism. This is implanted into the inferior vena cava using a [...]

Read the full article →

FDA Warns of potential Propecia Side Effects

July 27, 2011

Propecia Side Effects In addition to the sexual dysfunction side effects that many people are talking about today, users of Propecia who decide to stop taking the medication noted losing the hair that was grown while on the drug.  Therefore, in order to maintain growth and thickness, finasteride (Propecia) needs to be taken for the [...]

Read the full article →

New IVC Filter Module created

June 17, 2011

American Venous Forum Launches IVC Filter Module of American Venous Registry Improving Tomorrow’s Outcomes With Today’s Data ShareThis Email PDF Print The IVC Filter Module is launching at an extremely appropriate time as the FDA, doctors and patients are struggling with critical questions… Beverly, MA (PRWEB) June 16, 2011 Today the American Venous Forum (AVF) [...]

Read the full article →

Understanding Contingency Fees

April 2, 2011

If your case is settled, or won in court, you will be entitled to compensation, and the attorney representing you will receive his/her compensation from this compensation.  Most contingency fees are somewhere between 33% to 40% of whatever compensation is received.  If you decide to work with a personal injury lawyer, you will be asked [...]

Read the full article →

FDA Warns Against Topamax Use During Pregnancy

March 9, 2011

The Food and Drug Administration recently warned women of childbearing age and expectant mothers against the use of anti-convulsant drug, Topamax, as is poses rick of development of cleft lips or cleft palate deformities in newborn babies.  According to the FDA’s research data, newborns of women who take Topamax during their first trimester of pregnancy [...]

Read the full article →